Julie A. Buckmeier

1.6k total citations
20 papers, 1.3k citations indexed

About

Julie A. Buckmeier is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Julie A. Buckmeier has authored 20 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Julie A. Buckmeier's work include melanin and skin pigmentation (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Genetic factors in colorectal cancer (3 papers). Julie A. Buckmeier is often cited by papers focused on melanin and skin pigmentation (5 papers), Genomics, phytochemicals, and oxidative stress (3 papers) and Genetic factors in colorectal cancer (3 papers). Julie A. Buckmeier collaborates with scholars based in United States, Canada and United Kingdom. Julie A. Buckmeier's co-authors include Frank L. Meyskens, Nilou B. Tohidian, Stanley R. Hamilton, Mark J. Graham, David S. Alberts, Marianne Broome Powell, Susan E. McNulty, Rachel Gonzalez, Ravi S. Kahlon and Scott S. Zamvil and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Free Radical Biology and Medicine and Journal of Investigative Dermatology.

In The Last Decade

Julie A. Buckmeier

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie A. Buckmeier United States 15 632 339 275 267 241 20 1.3k
Fatouma Alimirah United States 25 851 1.3× 296 0.9× 208 0.8× 362 1.4× 290 1.2× 32 1.9k
Ceri Oldreive United Kingdom 15 1.2k 1.9× 626 1.8× 197 0.7× 329 1.2× 124 0.5× 26 1.8k
Fumihito Hosoi Japan 15 933 1.5× 418 1.2× 145 0.5× 227 0.9× 136 0.6× 22 1.3k
Subhas Chakrabarty United States 26 967 1.5× 543 1.6× 337 1.2× 91 0.3× 275 1.1× 64 1.7k
Carmela Ciccarelli Italy 20 941 1.5× 245 0.7× 136 0.5× 105 0.4× 383 1.6× 29 1.4k
Sujata Persad Canada 19 1.4k 2.2× 385 1.1× 190 0.7× 252 0.9× 303 1.3× 37 2.1k
Xiaoxian Zhao United States 21 925 1.5× 281 0.8× 148 0.5× 342 1.3× 104 0.4× 44 1.7k
Yi Luo China 24 895 1.4× 273 0.8× 160 0.6× 174 0.7× 499 2.1× 75 1.7k
Toshimitsu Suhara Japan 18 855 1.4× 179 0.5× 76 0.3× 352 1.3× 189 0.8× 21 1.4k
Haijuan Wang China 23 896 1.4× 526 1.6× 100 0.4× 169 0.6× 322 1.3× 66 1.6k

Countries citing papers authored by Julie A. Buckmeier

Since Specialization
Citations

This map shows the geographic impact of Julie A. Buckmeier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie A. Buckmeier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie A. Buckmeier more than expected).

Fields of papers citing papers by Julie A. Buckmeier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie A. Buckmeier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie A. Buckmeier. The network helps show where Julie A. Buckmeier may publish in the future.

Co-authorship network of co-authors of Julie A. Buckmeier

This figure shows the co-authorship network connecting the top 25 collaborators of Julie A. Buckmeier. A scholar is included among the top collaborators of Julie A. Buckmeier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie A. Buckmeier. Julie A. Buckmeier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thompson, Patricia A., Erin L. Ashbeck, Denise J. Roe, et al.. (2016). Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. JNCI Journal of the National Cancer Institute. 108(12). 75 indexed citations
2.
Thompson, Patricia A., Erin L. Ashbeck, Denise J. Roe, et al.. (2016). Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. JNCI Journal of the National Cancer Institute. 108(12). 45 indexed citations
3.
Tsikitis, Vassiliki L., Motomi Mori, Julie A. Buckmeier, et al.. (2016). MicroRNA Signatures of Colonic Polyps on Screening and Histology. Cancer Prevention Research. 9(12). 942–949. 22 indexed citations
4.
Tsikitis, Vassiliki L., Ian White, Motomi Mori, et al.. (2014). Differential expression of microRNA-320a, -145, and -192 along the continuum of normal mucosa to high-grade dysplastic adenomas of the colorectum. The American Journal of Surgery. 207(5). 717–722. 12 indexed citations
5.
Bartley, Angela N., Nila U. Parikh, Chiu‐Hsieh Hsu, et al.. (2013). Colorectal Adenoma Stem-like Cell Populations: Associations with Adenoma Characteristics and Metachronous Colorectal Neoplasia. Cancer Prevention Research. 6(11). 1162–1170. 10 indexed citations
6.
Thompson, Patricia A., Denise J. Roe, Julie A. Buckmeier, et al.. (2012). Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention. Cancer Prevention Research. 5(12). 1381–1393. 16 indexed citations
7.
Jacobs, Elizabeth T., et al.. (2011). Circulating fibroblast growth factor-23 is associated with increased risk for metachronous colorectal adenoma. Journal of Carcinogenesis. 10(1). 3–3. 17 indexed citations
8.
Bartley, Angela N., Patricia A. Thompson, Julie A. Buckmeier, et al.. (2009). Expression of gastric pyloric mucin, MUC6, in colorectal serrated polyps. Modern Pathology. 23(2). 169–176. 27 indexed citations
9.
Einspahr, Janine G., James Warneke, Kathylynn Saboda, et al.. (2006). Reproducibility and Expression of Skin Biomarkers in Sun-Damaged Skin and Actinic Keratoses. Cancer Epidemiology Biomarkers & Prevention. 15(10). 1841–1848. 14 indexed citations
10.
Shen, Lanlan, Yutaka Kondo, Gary L. Rosner, et al.. (2005). MGMT Promoter Methylation and Field Defect in Sporadic Colorectal Cancer. JNCI Journal of the National Cancer Institute. 97(18). 1330–1338. 382 indexed citations
11.
Cen, Dazhi, Rachel Gonzalez, Julie A. Buckmeier, et al.. (2002). Disulfiram induces apoptosis in human melanoma cells: a redox-related process.. PubMed. 1(3). 197–204. 121 indexed citations
12.
Meyskens, Frank L., Susan E. McNulty, Julie A. Buckmeier, et al.. (2001). Aberrant redox regulation in human metastatic melanoma cells compared to normal melanocytes. Free Radical Biology and Medicine. 31(6). 799–808. 99 indexed citations
13.
Meyskens, Frank L., et al.. (1999). Activation of nuclear factor-kappa B in human metastatic melanomacells and the effect of oxidative stress.. PubMed. 5(5). 1197–202. 81 indexed citations
14.
Meyskens, Frank L., et al.. (1997). Luminol‐Enhanced Chemiluminescent Response of Human Melanocytes and Melanoma Cells to Hydrogen Peroxide Stress. Pigment Cell Research. 10(3). 184–189. 54 indexed citations
15.
Powell, Marianne Broome, et al.. (1993). Protein kinase Cβ expression in melanoma cells and melanocytes: differential expression correlates with biological responses to 12-O-tetradecanoylphorbol 13-acetate. Journal of Cancer Research and Clinical Oncology. 119(4). 199–206. 25 indexed citations
16.
Hickie, Robert A., Mark J. Graham, Julie A. Buckmeier, & Frank L. Meyskens. (1992). Comparison of Calmodulin Gene Expression in Human Neonatal Melanocytes and Metastatic Melanoma Cell Lines. Journal of Investigative Dermatology. 99(6). 764–773. 11 indexed citations
17.
Buckmeier, Julie A., et al.. (1991). Expression of c-jun, jun-B, and c-fos Proto-Oncogenes in Human Primary Melanocytes and Metastatic Melanomas. Journal of Investigative Dermatology. 97(2). 349–353. 47 indexed citations
18.
Powell, Marianne Broome, Dennis J. Mitchell, Julie A. Buckmeier, et al.. (1990). Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenicity. International Immunology. 2(6). 539–544. 258 indexed citations
19.
Meyskens, Frank L., Stephen P. Thomson, & Julie A. Buckmeier. (1989). Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival. Clinical & Experimental Metastasis. 7(6). 627–632. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fatouma Alimirah Breakdown of academic impact, for papers by Ceri Oldreive Breakdown of academic impact, for papers by Fumihito Hosoi Breakdown of academic impact, for papers by Subhas Chakrabarty Breakdown of academic impact, for papers by Carmela Ciccarelli Breakdown of academic impact, for papers by Sujata Persad Breakdown of academic impact, for papers by Xiaoxian Zhao Breakdown of academic impact, for papers by Yi Luo Breakdown of academic impact, for papers by Toshimitsu Suhara Breakdown of academic impact, for papers by Haijuan Wang
Rankless by CCL
2026